The first participant was enrolled on March 4, 2024, and the last participant completed enrollment on July 15, 2024
Pinch a fold of skin and subcutaneous tissue between your thumb and forefinger
PubMed Central, Haenisch, Britta, et al
additionally, NMN treatment led to reduced mitochondrial ROS production and enhanced oxygen consumption rate 112
One of the most noticeable and worrisome side effects of injectable GLP-1s is muscle loss
The basal insulin dose was decreased by 20% at randomization, and Victoza was initiated at 0.6 mg/day and was titrated to 1.2 mg and 1.8 mg over the course of 2-3 weeks based on tolerability and an average fasting plasma glucose goal of 110 mg/dL